FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Method for genetic registration and correction of neurogenesis based on genetic constructs for the transfection of neurons is proposed, wherein the catecholaminergic neurons are transfected with the genetic construct of SEQ ID NO: 4, possessing the ability to stimulate neurogenesis and (or) inhibit neuronal degeneration. Invention makes it possible to carry out cell- and fentip-specific transfection of catecholaminergic neurons with the aim of targeting intracellular cascades, and also to visualize in vitro transfected cells by embedding in the developed genetic construct of a genetically encoded calcium indicator.
EFFECT: invention can be used in the field of medicine for the therapy of neurodegenerative diseases.
1 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR NEUROGENESIS CHEMOGENETIC RECORDING AND CORRECTION BASED ON GENETIC CONSTRUCTIONS FOR ASTROCYTES AND NEURONS TRANSFECTION | 2015 |
|
RU2630654C2 |
METHOD FOR GENETIC CONTROL OF EXOCYTOSIS BASED ON GENETIC CONSTRUCTIONS FOR ASTROGLIA CELLS TRANSFECTION | 2015 |
|
RU2633691C2 |
IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
GENETIC MAKE-UPS FOR ANTI-HIV THERAPY | 2010 |
|
RU2426788C1 |
GENETIC CONSTRUCT BASED ON CRISPR/Cas9 GENOME SYSTEM EDITING, CODING Cas9 NUCLEASE, SPECIFICALLY IMPORTED IN HUMAN CELLS MITOCHONDRIA | 2015 |
|
RU2634395C1 |
GENETIC CONSTRUCT CODING STRUCTURE OF T-CELL CHIMERIC RECEPTOR BASED ON SINGLE-CHAIN VHH ANTIBODIES SPECIFIC TO TUMOUR RECEPTOR CD47 FOR THE TARGETED IMMUNOTHERAPY OF MALIGNANT GROWTHS | 2017 |
|
RU2707535C2 |
GENETIC CONSTRUCT PMITOASCPF1, CODING NUCLEASE ASCPF1 WITH DETERMINANT OF IMPLANTATION IN THE MITOCHONDRIA OF HUMAN CELLS | 2016 |
|
RU2662994C2 |
VECTORS FOR TREATMENT OF FRIEDREICH'S ATAXIA | 2018 |
|
RU2774892C2 |
DOUBLE-STRANDED RNA CAPABLE OF REDUCING EXPRESSION OF MUTANT ALLELE C.607G>A OF HUMAN GNAO1 GENE | 2022 |
|
RU2816137C1 |
GENETIC CONSTRUCT FOR INDUCING PROLIFERATION OF PERIPHERAL MONOCYTES IN VITRO | 2017 |
|
RU2697797C2 |
Authors
Dates
2018-10-18—Published
2016-12-16—Filed